Loading...
Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts
PURPOSE: All currently available therapies for the treatment of pancreatic ductal adenocarcinoma (PDAC) show limited success. PDACs fast progression depends on the tumor characteristics and can be influenced by the microenvironment. The antibacterial drug acriflavine (ACF) has been shown to have ant...
Na minha lista:
| Udgivet i: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7369416/ https://ncbi.nlm.nih.gov/pubmed/32764982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S245134 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|